Raymond James & Associates La Jolla Pharmaceutical CO Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$20.13 - $34.02 $174,265 - $294,511
-8,657 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$28.97 - $33.27 $2,491 - $2,861
-86 Reduced 0.98%
8,657 $253,000
Q1 2018

May 14, 2018
SELL
$28.17 - $39.24 $905,186 - $1.26 Million
-32,133 Reduced 78.61%
8,743 $260,000
Q4 2017

Feb 14, 2018
SELL
$23.91 - $35.91 $76,512 - $114,911
-3,200 Reduced 7.26%
40,876 $1.32 Million
Q3 2017

Nov 13, 2017
BUY
$28.21 - $37.21 $1.24 Million - $1.64 Million
44,076
44,076 $1.53 Million

About LA JOLLA PHARMACEUTICAL CO

LJPC Quotes by TradingView
  • Ticker LJPC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,936,900
  • Market Cap $155M
More about LJPC
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email